# JL Poveda Andrés

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jl-poveda-andres/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26 |
| Field | Clinical Nutrition and Gastroenterology |
| h-index | 4 |
| i10-index | 0 |
| Last Known Institution | Hospital Universitari i Politècnic La Fe |
| OpenAlex ID | https://openalex.org/A5111653383 |
| Works | 41 |

## Researcher papers

- [CP-070 Interleukin-2 treatment of two patients with multifocal progressive leukoencephalopathy associated with hiv infection](https://scholariq.org/papers/cp-070-interleukin-2-treatment-of-two-patients-with-multifocal-progressive/)
- [\[Analyzing the evolution of a Pharmacy Department using a relative value unit system\].](https://scholariq.org/papers/analyzing-the-evolution-of-a-pharmacy-department-using-a-relative-value-unit/)
- [\[Profile of primary care physicians in a health area: a cluster analysis\].](https://scholariq.org/papers/profile-of-primary-care-physicians-in-a-health-area-a-cluster-analysis/)
- [4CPS-287 Impact of SARS-CoV-2 infection in acute myeloid leukaemia patients: experience of the Pethema registry](https://scholariq.org/papers/4cps-287-impact-of-sars-cov-2-infection-in-acute-myeloid-leukaemia-patients/)
- [CP-129 Defibrotide for sinusoidal obstruction syndrome: a single centre experience](https://scholariq.org/papers/cp-129-defibrotide-for-sinusoidal-obstruction-syndrome-a-single-centre/)
- [4CPS-070 Evaluation of avoided cost in clinical trials with immunotherapy in lung cancer](https://scholariq.org/papers/4cps-070-evaluation-of-avoided-cost-in-clinical-trials-with-immunotherapy-in/)
- [PS-066 Infusion reactions documented with different generic paclitaxel formulations by means of an adverse drug reactions reporting programme](https://scholariq.org/papers/ps-066-infusion-reactions-documented-with-different-generic-paclitaxel/)
- [CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis](https://scholariq.org/papers/cp-221-clinical-experience-with-intrathecal-rituximab-for-treatment-of/)
- [5PSQ-073 Usefulness of saliva in therapeutic drug monitoring of caffeine in preterm infants](https://scholariq.org/papers/5psq-073-usefulness-of-saliva-in-therapeutic-drug-monitoring-of-caffeine-in/)
- [4CPS-168 Effectiveness, safety and adherence to evolocumab in real clinical practice](https://scholariq.org/papers/4cps-168-effectiveness-safety-and-adherence-to-evolocumab-in-real-clinical/)
- [4CPS-096 Teduglutide versus home parenteral nutrition in paediatric population with short bowel syndrome](https://scholariq.org/papers/4cps-096-teduglutide-versus-home-parenteral-nutrition-in-paediatric-population/)

## Researcher topics

- [Clinical Nutrition and Gastroenterology](https://scholariq.org/topics/clinical-nutrition-and-gastroenterology/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Antibiotics Pharmacokinetics and Efficacy](https://scholariq.org/topics/antibiotics-pharmacokinetics-and-efficacy/)
- [Neonatal Health and Biochemistry](https://scholariq.org/topics/neonatal-health-and-biochemistry/)

## Researcher university

- [Hospital Universitari i Politècnic La Fe](https://scholariq.org/institutions/hospital-universitari-i-politecnic-la-fe/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.